ClinicalTrials.gov
ClinicalTrials.gov Menu

Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology (CAP2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01760291
Recruitment Status : Active, not recruiting
First Posted : January 4, 2013
Last Update Posted : June 14, 2017
Sponsor:
Information provided by (Responsible Party):
Boston Scientific Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : February 2019
  Estimated Study Completion Date : February 2019